Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

[Decreased retraction of blood clots in patients with venous thromboembolic complications].

Bredikhin RA, Peshkova AD, Maliasev DV, Batrakova MV, Le Min J, Panasiuk MV, Fatkhullina LS, Ignat'ev IM, KhaÄ­rullin RN, Litvinov RI.

Angiol Sosud Khir. 2018;24(1):21-28. Russian.

PMID:
29688191
2.

Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.

Buglak NE, Batrakova EV, Mota R, Bahnson ESM.

Oxid Med Cell Longev. 2018 Feb 14;2018:2468457. doi: 10.1155/2018/2468457. eCollection 2018. Review.

3.

Author Correction: Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.

Rodriguez M, Lapierre J, Ojha CR, Kaushik A, Batrakova E, Kashanchi F, Dever SM, Nair M, El-Hage N.

Sci Rep. 2018 Mar 14;8(1):4778. doi: 10.1038/s41598-018-23078-y.

4.

Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations.

Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, Kabanov AV, Batrakova EV.

Nanomedicine. 2018 Jan;14(1):195-204. doi: 10.1016/j.nano.2017.09.011. Epub 2017 Oct 2.

PMID:
28982587
5.

Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, Kabanov AV.

Biomaterials. 2017 Oct;142:1-12. doi: 10.1016/j.biomaterials.2017.07.011. Epub 2017 Jul 10.

PMID:
28715655
6.

Macrophages with cellular backpacks for targeted drug delivery to the brain.

Klyachko NL, Polak R, Haney MJ, Zhao Y, Gomes Neto RJ, Hill MC, Kabanov AV, Cohen RE, Rubner MF, Batrakova EV.

Biomaterials. 2017 Sep;140:79-87. doi: 10.1016/j.biomaterials.2017.06.017. Epub 2017 Jun 18.

7.

Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.

Rodriguez M, Lapierre J, Ojha CR, Kaushik A, Batrakova E, Kashanchi F, Dever SM, Nair M, El-Hage N.

Sci Rep. 2017 May 12;7(1):1862. doi: 10.1038/s41598-017-01819-9. Erratum in: Sci Rep. 2018 Mar 14;8(1):4778.

8.

Development and regulation of exosome-based therapy products.

Batrakova EV, Kim MS.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):744-57. doi: 10.1002/wnan.1395. Epub 2016 Feb 17. Review.

PMID:
26888041
9.

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.

Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV.

Nanomedicine. 2016 Apr;12(3):655-664. doi: 10.1016/j.nano.2015.10.012. Epub 2015 Nov 14.

10.

Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections.

Roy U, Barber P, Tse-Dinh YC, Batrakova EV, Mondal D, Nair M.

Front Microbiol. 2015 Sep 17;6:948. doi: 10.3389/fmicb.2015.00948. eCollection 2015. Review.

11.

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.

Roy U, Ding H, Pilakka-Kanthikeel S, Raymond AD, Atluri V, Yndart A, Kaftanovskaya EM, Batrakova E, Agudelo M, Nair M.

Int J Nanomedicine. 2015 Sep 18;10:5819-35. doi: 10.2147/IJN.S68348. eCollection 2015.

12.

Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Batrakova EV, Kim MS.

J Control Release. 2015 Dec 10;219:396-405. doi: 10.1016/j.jconrel.2015.07.030. Epub 2015 Aug 1. Review.

13.

Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky M, Kabanov AV, Batrakova EV.

J Control Release. 2015 Jun 10;207:18-30. doi: 10.1016/j.jconrel.2015.03.033. Epub 2015 Mar 31.

14.

GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model.

Zhao Y, Haney MJ, Gupta R, Bohnsack JP, He Z, Kabanov AV, Batrakova EV.

PLoS One. 2014 Sep 17;9(9):e106867. doi: 10.1371/journal.pone.0106867. eCollection 2014.

15.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

Nanomedicine (Lond). 2014 Jul;9(9):1403-22. doi: 10.2217/nnm.13.115. Epub 2013 Nov 18.

16.

[Hygienic assessment of waste of soda production].

Samutin NM, Vaisman YI, Rudakova LV, Kalinina EV, Glushankova IS, Batrakova GM.

Gig Sanit. 2013 Mar-Apr;(2):30-3. Russian.

PMID:
24003694
17.

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

Haney MJ, Zhao Y, Harrison EB, Mahajan V, Ahmed S, He Z, Suresh P, Hingtgen SD, Klyachko NL, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

PLoS One. 2013 Apr 19;8(4):e61852. doi: 10.1371/journal.pone.0061852. Print 2013.

18.

Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Manickam DS, Brynskikh AM, Kopanic JL, Sorgen PL, Klyachko NL, Batrakova EV, Bronich TK, Kabanov AV.

J Control Release. 2012 Sep 28;162(3):636-45. doi: 10.1016/j.jconrel.2012.07.044. Epub 2012 Aug 10.

19.

Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Zhao Y, Haney MJ, Mahajan V, Reiner BC, Dunaevsky A, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

J Nanomed Nanotechnol. 2011 Sep 10;S4. pii: 003.

20.

Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.

Haney MJ, Suresh P, Zhao Y, Kanmogne GD, Kadiu I, Sokolsky-Papkov M, Klyachko NL, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

Nanomedicine (Lond). 2012 Jun;7(6):815-33. doi: 10.2217/nnm.11.156. Epub 2012 Jan 11.

Supplemental Content

Loading ...
Support Center